Open access peer-reviewed chapter

GABAergic Synapse Dysfunction and Repair in Temporal Lobe Epilepsy

Written By

Meghan A. Van Zandt and Janice R. Naegele

Submitted: July 20th, 2016 Reviewed: December 12th, 2016 Published: June 21st, 2017

DOI: 10.5772/67218

Chapter metrics overview

1,749 Chapter Downloads

View Full Metrics


Severe medial temporal lobe epilepsy (mTLE) is often associated with pharmacoresistant seizures, impaired memory and mood disorders. In the hippocampus, GABAergic inhibitory interneuron dysfunction and other neural circuit abnormalities contribute to hyperexcitability, but the mechanisms are still not well understood. Experimental approaches aimed at correcting deficits in hippocampal circuits in mTLE include attempts to replace GABAergic interneurons through neural stem cell transplantation. Evidence from studies in rodent mTLE models indicates that transplanted GABAergic progenitor cells integrate into the hippocampus, form inhibitory synapses, reduce seizures and improve cognitive deficits. Here, we review current work in this field and describe potential molecular mechanisms underlying successful transplantation.


  • GABA
  • temporal lobe
  • epilepsy
  • hippocampus
  • GABAergic
  • interneurons
  • neuroligin
  • neurexin
  • seizures
  • inhibition
  • gephyrin
  • collybistin
  • cognition
  • spatial memory
  • behaviour
  • transplantation
  • therapy
  • stem cells

1. Introduction

Epilepsy is a brain disorder characterized by a predisposition to generate epileptic seizures that may have subsequent neurological, cognitive, psychological and social effects. Many patients with severe medial temporal lobe epilepsy (mTLE) experience intractable seizures and degenerative changes in the temporal lobes of the brain, particularly the hippocampus [1]. Pharmacological treatments for these patients may become ineffective [25], and chronic severe pharmacoresistant seizures in mTLE patients can lead to memory impairments, anxiety and depression. While removing epileptogenic foci provides better seizure control in these patients, surgery may not be feasible if the seizures are generated bilaterally or at multiple foci. Moreover, one of the challenges of treating mTLE is that seizures trigger neuroplastic changes in the adult hippocampus, including axonal sprouting, rewiring and abnormal migration and growth of new dentate granule cells (GCs). Which of these changes are necessary and sufficient for generating recurrent seizures that can be corrected through cell-replacement therapies is not well known.

A major focus of current research is developing rigorous protocols for deriving human neural stem cells from pluripotent stem cells (PSCs) and directing their differentiation into the specific types of neurons, including subtypes of GABAergic interneurons. Additional studies are focusing on the circuit-level and molecular mechanisms that regulate incorporation of transplanted mouse or human GABAergic interneuron progenitors into host brains. Studies of the functional impact of transplanting GABAergic interneurons into the brain and spinal cord in models of different neurological disorders are still in their infancy [6], and relatively little is known about mechanisms guiding the survival, differentiation and synaptic integration of transplanted GABAergic interneurons in the adult brain. This review focuses on current work in this field of regenerative medicine and new directions for regenerating neural circuits.


2. Pathology of medial temporal lobe epilepsy

Dentate gyrus (DG) reorganization has been extensively studied in rodent models of mTLE, particularly the chemoconvulsant models that employ kainic acid or pilocarpine injections to induce status epilepticus (SE). Prominent features of DG reorganization are the loss of glutamatergic mossy cells and subsets of GABAergic interneurons. Depletion of these neuronal populations results in loss of feed-forward inhibition of DG GCs [711]. Some of the principal cells of CA1 and CA3, as well as adult-generated GCs of the DG born around the time of SE, sprout excitatory axon collaterals, increasing recurrent excitatory drive between neighbouring neurons [12, 13]. Many somatostatin (SOM) -expressing GABAergic interneurons degenerate in the DG and CA1 of the hippocampus in mTLE, and some residual GABAergic interneurons form compensatory synaptic connections [10, 1418]. Axonal sprouting by surviving hippocampal GABAergic interneurons increases the number of inhibitory synaptic puncta above control values in chronically epileptic rodents, although this response is insufficient to counter the development of spontaneous recurrent seizures typical of mTLE [15, 19]. Together, these studies suggest that replacing hippocampal GABAergic interneurons in pharmacoresistant mTLE may be a promising strategy for suppressing seizures (Figure 1).

Figure 1.

Studies of GABAergic interneuron transplantation are investigating whether it is feasible to replace populations of endogenous interneurons damaged by temporal lobe epilepsy. (A) In the non-epileptic mouse dentate gyrus (DG), self-renewing, quiescent Type 1 progenitor cells in the subgranular zone (SGZ) extend radial glial processes through the granule cell layer (GCL) (1). They divide asymmetrically to produce Type 2 progenitors (2) which further divide to generate pools of migratory Type 3 neuroblasts (3). As these neuroblasts mature, they differentiate into GCs, migrate into the GCL, extend their dendrites towards the molecular layer (ML)(4) and project axons to hilar interneurons and mossy cells and CA3 pyramidal cells (5). Inhibitory GABAergic interneurons (6) synapse with GCs and provide inhibition. GCs are shown in yellow, inhibitory interneurons in light blue and pyramidal cells in magenta. (B) High-resolution confocal image of retrovirally labelled GCs (green) and neuronal nuclei (NeuN, red) in the naïve mouse hippocampus. White arrow indicates a normal Type 1 progenitor cell in the SGZ. (C) In mTLE, some of the hilar GABAergic interneurons die, resulting in an overall loss of inhibition to GCs (1). Additionally, some adult-generated GCs undergo abnormal migration into the hilus, becoming ectopic. They typically form abnormal dendrites and sprout recurrent axonal collaterals, forming excitatory feedback projections onto other GCs (3) as well as abnormal excitatory projections to the CA3 pyramidal cells (4) [2030]. GCs are shown in yellow; an abnormal, ectopic GC in orange; and pyramidal cells in magenta. (D) High-resolution confocal image of retrovirally labelled GCs (red) in the hippocampus of a mouse with mTLE. Nuclei are marked using a Nissl stain (blue). White arrows show ectopic GCs born after induction of epilepsy located in abnormal locations in the hilus. (E) Studies employing transplantation of GABAergic progenitors into either the normal or epileptic hippocampus show that they migrate away from the site of injection and form dense axonal arbors throughout the hilus, GCL and molecular layer. These interneurons appear to form functional synapses with hyperexcitable GCs, including those with aberrant morphologies (1), increasing synaptic inhibition in the epileptic circuit. GCs are shown in yellow; abnormal, ectopic GC in orange; transplanted GABAergic inhibitory interneurons in green; and pyramidal cells in magenta [31]. (F) High-resolution confocal image of a retrovirally labelled GC (red) receiving dense synaptic contacts from transplanted MGE-derived GABAergic progenitors (green). Nuclei are labelled using Nissl staining (blue) [31].

GCs are a type of excitatory glutamatergic neuron in the granule cell layer (GCL) of the DG of the hippocampus, and studies suggest that they are relatively more resistant to seizure-induced injury than many other cell types in the hippocampus [32]. They form axons called the mossy fibres that project to CA3 pyramidal neurons and other cell types [1, 3335]. GCs are generated throughout life [28, 3641]. In rodent models of mTLE and human patients, many GCs, born around the time of SE, develop altered morphology, excitability and connectivity. These adult-generated GCs form recurrent axon collaterals in the inner molecular layer, a form of neuroplasticity termed mossy fibre sprouting (MFS) [26]. Overgrowth of mossy fibre recurrent collaterals onto GCs and pyramidal cells contributes to a hyperexcitable dentate environment [27, 29, 4244].

As demonstrated by computer simulations, a few hubs of highly interconnected GCs are sufficient to create a hyperexcitable network [30, 45]. Additional epilepsy-induced neuroplastic changes to the DG include GC dispersion, formation of GC basal dendrites and ectopic migration of GCs into the hilus of the DG [2325, 4650]. Many adult-generated GCs born in epileptic rodents also have reduced dendritic spines and hypertrophic cell bodies [20, 214451]. These cells often have higher baseline firing rates than normally positioned GCs in epileptic animals and non-epileptic controls and more depolarized resting membrane potentials, predisposing them to hyperexcitability [22]. Although increasing adult neurogenesis is not sufficient to cause seizures, it contributes to hyperexcitability [52, 53].


3. Cognitive changes in medial temporal lobe epilepsy

Severe mTLE is linked to a number of comorbidities including cognitive deficits, heightened anxiety, increased aggression and depression [54, 55]. Rodents with mTLE show decreased social recognition, greater preference for closed arms in the elevated zero or plus maze test for anxiety and longer periods of immobility in the forced swim test for depression [56]. Additionally, a number of studies demonstrated severe learning deficits in the Morris water maze test of spatial memory [57, 58] and other spatial memory tasks [59]. Human mTLE patients exposed to virtual environments that test spatial memory also showed memory deficits [60, 61].

Changes in the properties of hippocampal and entorhinal cortex circuits may be responsible for cognitive changes in mTLE, but the nature of these changes is not well understood. Both human and rodent spatial memory formation and recall are dependent on place cells in the hippocampus and grid cells in the entorhinal cortex. These important cells exhibit distinct, spatially specific firing patterns, forming a topographical memory map of an area as an individual moves through space [6265]. Hippocampal inhibitory interneurons, similar to place cells, show distinct, spatially specific discharges, implicating a role in the formation and fine tuning of spatial memories [66, 67]. Studies suggest that impairments in receptive field properties of the grid and place cells may occur in mTLE [6871].

The regulation by inhibitory interneurons of various brain rhythms may also become altered, as rodents with mTLE show distinctly lower frequency and power of theta rhythms correlated with poor performance in spatial memory tasks [7274]. Although the exact alterations occurring in the grid-place cell network are not yet clear, it is evident that the hyperexcitable firing of GCs and the overall disinhibition of the network by loss of inhibitory interneurons severely disrupts spatial memory formation [72, 7579]. The disinhibition of the hippocampal networks following epileptogenesis and the subsequent development of spatial memory deficits suggest that the loss of inhibitory interneurons may disrupt place fields, providing a further rationale for cell-based therapies aimed at GABAergic interneuron transplantation.


4. Seizure suppression following transplantation of medial ganglionic eminence-derived neural progenitors

Initial studies established proof of concept for cell-based therapies for treating epilepsy by demonstrating that transplants of non-neural cells engineered to release GABA non-synaptically could increase seizure thresholds [80]. Increasingly, studies have aimed to identify the functional classes of interneurons that can migrate, integrate and suppress seizures in different models of epilepsy in rodents. The large variety of functional classes of cortical inhibitory interneurons and their sites of origin in the ventricular zones of the embryonic forebrain have been extensively studied. During development, forebrain GABAergic interneurons are born in the embryonic ventricular regions called the ganglionic eminences, including the medial, lateral and caudal ganglionic eminences (MGE, LGE, CGE). These transient proliferative zones lining the forebrain lateral ventricles generate different types of GABAergic interneuron progenitors, which then migrate to their final destinations in the forebrain, including the cerebral cortex, hippocampus and striatum [8183]. Forebrain GABAergic progenitors expressing SOM or parvalbumin (PV) emerge from the MGE in early embryonic life and migrate tangentially into the cerebral cortex and hippocampus [84].

In naïve rodents and different epilepsy models, transplanted GABAergic interneuron progenitors from the embryonic MGE have been found to be highly migratory, a prerequisite for transplantation therapies aimed at repairing large brain areas. MGE-derived GABAergic progenitors transplanted into postnatal 3–4-day old mouse cerebral cortex differentiated into inhibitory interneurons expressing markers of mature GABAergic phenotypes, including PV, SOM, calretinin (CR) and neuropeptide Y (NPY), and displayed mature firing properties characteristic of inhibitory interneurons [85]. MGE-derived PV-positive interneurons transplanted into naïve postnatal 1–2-day old pups integrated into the endogenous circuitry and, upon maturation, displayed firing properties similar to endogenous PV-expressing interneurons and formed functional synapses onto pyramidal neurons [86]. In a mouse model of mTLE generated through neurotoxin-induced ablation of GABAergic interneurons, MGE transplantation significantly increased inhibitory postsynaptic currents (IPSCs) in CA1 pyramidal cells and reduced seizure frequency and severity [87]. These grafts contained high percentages of GABAergic interneurons that co-expressed PV, NPY or CR. Transplanting MGE cells into an epilepsy model caused by mutations of the Kv1.1 potassium channel also increased IPSCs in nearby endogenous pyramidal cells [88]. Additionally, MGE cell transplants into a cyclin D2 knockout model of hippocampal disinhibition restored lost inhibitory input and normalized hyperactivity and fear conditioning [89].

The efficacy of MGE cell transplantation for controlling seizures has also been studied in chemoconvulsant models of mTLE, including the kainic acid and pilocarpine (PILO) models. In an early ground-breaking study in the rat kainic acid model, Shetty and colleagues transplanted neurospheres derived from embryonic day-14 rat MGE progenitors and found that they reduced seizure duration, total time spent in seizures and seizure severity; however, these grafts failed to improve spatial memory deficits [90]. It is important to note that the degree of cognitive impairment may differ between kainic acid or pilocarpine models, different species and even different strains of mice [91, 92].

The mouse PILO model shows a pattern of loss of hippocampal interneurons that is similar to human mTLE, making this model highly appropriate for preclinical studies investigating GABAergic interneuron transplantation [93]. Work from our laboratory showed that MGE cells transplanted into the hilus of the DG led to significant reductions in seizure frequency, duration and severity in the mouse PILO model [31]. The transplanted neurons matured into GABAergic interneurons that expressed CB, SOM or PV and formed dense networks of inhibitory synapses onto dentate GCs. Optogenetic experiments in hippocampal slices from these mice showed that light-induced depolarization of MGE transplants expressing channelrhodopsin (ChR2) triggered strong postsynaptic inhibitory currents in GCs, indicating that the transplanted neurons had integrated synaptically. These findings suggest that seizure suppression can be achieved with focal transplants into the DG. In this study, which employed continuous video-EEG recording for periods of up to 3 months, some of the mice show a reoccurrence of seizures several months after transplantation, suggesting that achieving enduring seizure suppression may require more widespread dispersion of the transplanted interneurons throughout different subfields of the hippocampus. Determining the optimal sites and cell types for permanent seizure suppression will be important for moving into clinical applications.


5. Transplantation therapy using human embryonic stem cell-derived progenitors

For treating patients with severe mTLE, sources of human interneurons are required. Previous work showed that differentiating human embryonic stem cells (hESCs) into GABAergic inhibitory interneuron progenitors can be achieved using specific combinations of signalling molecules and growth factors [94100]. Carpentino et al. (2008) found that maturation of transplanted mouse or hESCs is highly dependent on the environment into which the cells are transplanted. For instance, in the mouse systemic kainic acid model, it was shown that ESC-derived neural progenitors transplanted in the CA3 area tended to migrate into the DG and differentiate into GCs, whereas those implanted into the fimbria tended to mature into astrocytes [101]. Lee et al. also transplanted undifferentiated hESCs into the CA3 region of the hippocampus in epileptic rats. Some of these differentiated into GABAergic interneurons (~21% of engrafted cells) and at 8 weeks post transplantation displayed immature morphology. Even with low numbers of GABAergic neurons, the animals with transplants showed reduced seizure frequency and seizure duration for 2–3 months. EEG recordings in these animals were limited to 60 hours per week, with a 2-week recording period, during daylight hours only. Additionally, when tested 3 months after transplantation, improvements in Morris water maze performance were not found [102]. More recent studies have focused on purified, fate-determined populations of hESCs for transplantation. Treating hESCs with the signalling molecule sonic hedgehog (SHH) or a sonic hedgehog agonist (SAG), in combination with modulating the WNT and FGF signalling pathways, can be used in vitro to induce ventral forebrain neural fates and MGE-like cell types [97100, 103106]. Ventralized hESC-derived progenitors have identities similar to that of mouse MGE-derived GABAergic interneuron progenitors, potentially allowing the large-scale in vitro production of human cells for therapies to treat clinical disorders [94]. However, undifferentiated hESCs can cause teratomas, making it important to develop protocols for eliminating them prior to transplantation [107].

Evidence that fate-directed human GABAergic interneuron progenitors integrate into the epileptic circuitry of the hippocampus following transplantation into the hilus has emerged in several recent studies. To reduce immune rejection of cell grafts, human and mouse ESC transplantation studies generally use immunodeficient host animals. The nonobese diabetic (NOD)-severe combined immunodeficiency (SCID) mice are an immunodeficient mouse strain lacking mature T and B cells and with reduced natural killer (NK) cell activity. Another mouse strain, the Nod-scid-gamma (NSG) triple mutant, has a mutation at the interleukin-2 receptor (IL-2R) γ-chain locus. This strain shows the highest impairment in T-cell, B-cell and NK-cell development, resulting in low graft rejection [108]. Both strains have been used to study differentiation of ESC-derived GABAergic interneurons [109].

In a recent study in which hESC-derived progenitors were differentiated in vitro into MGE-like progenitors and transplanted into NSG mice, the transplanted cells differentiated into GABAergic neurons expressing SOM, PV, CB, CR or NPY after approximately 4 months. Additionally, optogenetic stimulation of the transplanted cells produced action potentials and resulted in IPSCs in endogenous hippocampal neurons, suggesting successful synaptic integration into the existing circuitry of the hippocampus. Video-EEG monitoring of these animals 3 months post-transplant showed reduced numbers of seizures in engrafted animals [110]. However, the EEG monitoring was only for short durations of 5–10 days, which is likely too brief a period to reliably evaluate seizures in rodent chemoconvulsant models, due to the clustered and periodic nature of the spontaneous recurrent seizures.


6. Ameliorating cognitive and behavioural abnormalities in epilepsy by transplantation of GABAergic interneurons

Inconsistent results regarding spatial memory improvement have been reported following GABAergic interneuron transplantation. In the Morris water maze test of spatial memory, C57BL/6 mice with PILO induced mTLE and received mouse MGE cell transplants showed significantly reduced escape latencies in training, significantly more platform crossings in the probe trial; improved path efficiency; and a greater amount of time spent in the target quadrant than epileptic controls [111]. In another study, rats with mTLE that MGE-derived stem cell grafts showed no improvements in the Morris water maze task 8 weeks post-engraftment relative to non-engrafted mTLE controls [90]. However, transplantation took place approximately 3 months following induction of epilepsy, a longer time interval than other studies. The lack of cognitive improvement at this later transplantation time point suggests a potentially limited time window in which transplanted GABAergic interneurons must integrate to confer cognitive improvements. In a third study in NSG mice with mTLE, engrafted hESC-derived GABAergic interneuron progenitors appeared to improve performance in the Y-maze test of spatial memory and memory in the novel recognition test [110].

Behavioural tests also suggested that mTLE mice receiving interneuron grafts were less hyperactive and aggressive, compared to mTLE controls with only intrahippocampal injections of media. In the handling test of aggression, in which mice are scored for aggressive reactions to a series of increasingly uncomfortable stimuli, TLE mice with hESC or foetal mouse MGE interneuron transplants scored significantly lower in aggression ratings than controls [109, 110]. These transplants also reduced hyperactive behaviour [110]. Taken together, these results suggest that both rodent and human GABAergic interneuron transplants may ameliorate some of the psychological comorbidities in rodents with mTLE. While the Morris water maze is currently one of the standard tests in the industry for spatial memory, rodents with mTLE often exhibit a phenomenon known as thigmotaxis, in which animals will locomote or swim adjacent to the walls of an apparatus or make repeated circles [91, 112]. In such animals, it is uncertain whether the data reflect poor spatial memory or an anxiety phenotype. Therefore, alternative spatial memory tests should be used to gain a more complete understanding of how GABAergic interneuron transplantation affects cognition. An alternative test of hippocampal-dependent spatial memory is a modification of the novel object recognition test in which animals must learn to recognize that a previously familiar object has changed location. This test, called novel object location task, takes advantage of the rodent preference for novelty and desire to explore changes in its environment [113, 114]. Another test of spatial memory is the Barnes maze, consisting of an elevated platform with closed holes around the circumference. One hole is available for escape into a dark box. Remaining on the platform is unpleasant to the rodent, due to bright lights, fans and/or loud ambient noise, encouraging a swift escape to the box. As this test measures a very natural desire to escape an unpleasant environment, it is considered an effective test of normal rodent behaviour and spatial memory [115]. The Barnes maze also has no walls, eliminating thigmotaxis, although care must be taken to prevent animals from falling from the raised platform. Additional tests of spatial memory include the Y-maze, T-maze and the radial arm maze, all of which measure the ability of a rodent to remember previously travelled areas [116121]. This extensive array of spatial memory tests can provide a more complete picture of the behavioural improvements following GABAergic interneuron transplantation in rodents with mTLE.

Currently, most testing of aggression has been done using the handling test, which, while effective, is an unnatural stimulus to the rodent [110, 111]. In addition to the handling test, the resident-intruder test can be used to analyse the response of a rodent to more natural stimuli. Male rodents are territorial, and the resident-intruder test measures the aggressive reactions to a male rival within their space. Although care must be taken to avoid injury to animals, this test measures an innate animal response and can be an effective measure of aggression in mTLE animals with transplants [122].

Although heightened anxiety is a common and well-characterized comorbidity in rodent mTLE models and human patients, surprisingly little work has been done to examine the effects of GABAergic transplants on correcting anxiety phenotypes. As rodents with mTLE have a tendency to exhibit thigmotaxis, which skews results in tests such as the open field test or the Morris water maze [91, 112], paradigms such as the elevated plus maze, elevated zero maze or the light-dark box can be used to provide more accurate measures of anxiety in rodents with mTLE [123128].


7. GABAergic synapse formation and stability: potential mechanisms of transplanted cell integration

Relatively few studies have examined the molecular mechanisms responsible for guiding synaptic integration of transplanted cells into mature neural circuits. Previous findings suggest that cell-cell interactions mediate the formation and stabilization of both excitatory and inhibitory synapses [129131]. The synaptic scaffolding complex between GABAergic interneurons and their postsynaptic targets in the developing brain may also guide recruitment and stabilization of the new synaptic connections formed by transplanted interneurons (Figure 2).

Figure 2.

Interactions between cell surface molecules that are binding partners provide a potential mechanism for forming or stabilizing new synapses between transplanted GABAergic interneurons and endogenous neurons in the hippocampus. GABAergic synapse formation is coordinated by multiple molecules in the pre- and postsynaptic sites. Binding between presynaptic neurexin molecules and postsynaptic neuroligin2 (NLGN2) molecules may be important for initial formation or maintenance of GABAergic synapses. NLGN2 is associated with a postsynaptic complex containing collybistin, gephyrin and GABAARs, which are necessary in the formation of functional inhibitory circuitry. Collybistin, gephyrin, NLGN2 or GABAAR subunit γ2 deficiency results in impaired inhibitory synapses [132141].

The synaptic scaffolding protein gephyrin is a tubulin-binding protein that forms a latticework structure of hexagonal trimers that regulate GABAA receptor clustering at synaptic sites [142, 143]. Gephyrin stabilizes inhibitory synapses and is required for proper function. Genetic reduction of the γ2 subunit of GABAA receptors, a primary binding partner of gephyrin in GABAergic synapses, also severely reduces gephyrin and GABAA receptor clustering required for functional inhibitory synapses [132]. Repression of gephyrin expression causes a similar loss of clustering, revealing an interdependent relationship between the two synaptic binding partners necessary for proper inhibitory synapse formation and function [132, 144, 145]. Increases in endogenous gephyrin in response to compensatory surviving interneuron sprouting may also make the epileptic hippocampus a more receptive environment for new inhibitory synapses to form [146]. Gephyrin is significantly decreased in the first few weeks post-SE followed by a significant increase back towards normal levels at around 1 month post-SE [147]. Following transplantation, a majority of engrafted GABAergic interneuron synaptic boutons were associated with postsynaptic gephyrin clusters, indicating that this vital synaptic scaffolding component may be recruited to sites of new GABAergic synapse formation in the adult hippocampus [31].

Collybistin, another GABAergic synaptic scaffolding component, binds to both gephyrin and Neuroligin 2 (NLGN2) and may facilitate gephyrin-mediated clustering of GABAA receptors. Collybistin is a GDP/GTP-exchange factor that interacts directly with gephyrin in the inhibitory synaptic scaffold [131, 133, 148150]. Collybistin-deficient mice display reduced clustering of gephyrin and GABAA receptors, reduced synaptic inhibition and altered synaptic plasticity [131, 141].

NLGN2 is part of a family of cell adhesion molecules implicated in synapse formation and stability. NLGN2 localizes only to GABAergic inhibitory synapses, where it is associated with neurexin, its presynaptic binding partner [151153]. NLGN2 is part of the molecular scaffolding complex that includes collybistin and gephyrin [133]. NLGN2-deficient mice show decreased inhibitory function, as well as a variety of cognitive and behavioural comorbidities, such as increased anxiety, aggression and disruptions in spatial memory formation, similar to those seen in mTLE and other neurological disorders [129, 136, 137, 154157]. Various studies have shown that binding between NLGN2 and neurexin induces inhibitory synapse formation [130, 158] and stabilization [135, 159], even in non-neuronal cell types [160].

GABAA receptor subunit composition may also play a role in the integration and stabilizing influence of transplanted inhibitory interneurons. Composition of GABAA subunits is impacted by the pathological changes induced in mTLE [161163]. DG GCs, which are significant propagators of hyperexcitability in mTLE, are particularly enriched in the δ subunit of GABAA receptors in the normal brain; these receptors have a very high affinity for GABA and are strongly involved in tonic inhibition [164166] at extrasynaptic sites [167]. In general, hippocampal neurons express multiple subunits, including abundant α, β, δ and γ subunits, with δ primarily restricted to GCs of the DG, with additional expression of other subunits in the CA1 and CA3 areas [168]. As such, it is apparent that GABAA receptors in the hippocampus are composed of a diverse pool of subunits that regulate inhibitory input. In mTLE, the composition of GABAA subunits becomes altered. Similar to the upregulation of gephyrin during the chronic phase of mTLE in response to compensatory interneuron sprouting, the γ2 and α subunits also show increased expression in the hippocampus. Conversely, expression of the δ subunit decreases days after the initial epileptic event and remains depressed into the chronic stages of mTLE [169]. It is not known whether synapses formed by surviving inhibitory interneurons are capable of recruiting the necessary subunit composition for proper inhibition, considering the overall depletion of δ subunits compared to γ2 and α. Moreover, whether transplanted, healthy GABAergic inhibitory interneurons can recruit all of the normal subunits to inhibitory synapses is not known. Further investigation of subunit composition within the epileptic hippocampus post transplantation will be necessary to investigate whether transplantation normalizes GABAA receptor composition.


8. Conclusion

While safe and effective stem cell therapies for treating neurological disorders, including severe mTLE, may be years away from the clinic, recent work has increased scientific understanding of how to derive specific types of human neurons for transplantation and how to evaluate functional changes that result. Because human neuron maturation takes many months or years, transplantation studies in rodents are limited in the kinds of information they can provide about the potential therapeutic effects of these cells in clinical populations. Recent studies have utilized a wide range of experimental tools, including electrophysiology, immunohistochemistry, optogenetics, chemogenetics and behavioural assays to assess learning, memory, anxiety, social behaviour and depression. These approaches are aiding studies to evaluate synaptic integration and functionality of human neural stem cell transplants for treating epilepsy.



We would like to thank Nicholas Woods, Bryan Luikart and Elizabeth Paquette for their assistance with retroviral labelling of GCs and confocal images. Work in our lab was supported by NINDS grant R15NS072879-01A1, Connecticut Stem Cell Established Investigator Grant and a Challenge Award from Citizens United for Research in Epilepsy (J.R.N.).


  1. 1. Dulla, C.G., Coulter, D.A., and Ziburkus, J., From molecular circuit dysfunction to disease case studies in epilepsy, traumatic brain injury, and Alzheimer’s disease. The Neuroscientist, 2016. 22(3): pp. 295–312.
  2. 2. Orozco-Suárez, S., Escalante-Santiago, D., Feria-Romero, I., Ureña-Guerrero, M.E., Rocha, L., Alonso-Vanegas, M.A., Villeda-Hernandez, J., Velasco, A., Abnormalities of GABA System and Human Pharmacoresistant Epilepsy, in Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies, L. Rocha and E.A. Cavalheiro, Editors. 2013, Springer New York: New York, NY. pp. 127–147.
  3. 3. Rubio-Donnadieu, F., Pharmacoresistance and Epilepsy, in Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies, L. Rocha and E.A. Cavalheiro, Editors. 2013, Springer New York: New York, NY. pp. 1–9.
  4. 4. van Vliet, E. A., Aronica, E., Gorter, J., Role of blood–brain barrier in temporal lobe epilepsy and pharmacoresistance. Neuroscience, 2014. 277: pp. 455–473.
  5. 5. Alexopoulos, A.V., Pharmacoresistant epilepsy: definition and explanation. Epileptology, 2013. 1(1): pp. 38–42.
  6. 6. Tyson, J.A. and Anderson, S.A., GABAergic interneuron transplants to study development and treat disease. Trends in Neurosciences, 2014. 37(3): pp. 169–177.
  7. 7. de Lanerolle, N.C., Kim, J., Robbins, R., Spencer, D., Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Research, 1989. 495(2): pp. 387–395.
  8. 8. Tóth, K., Erőss, L., Vajda, J., Halász, P., Freund, T.F., Maglóczky, Z., Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus. Brain: A Journal of Neurology, 2010. 133(9): pp. 2763–2777.
  9. 9. Swartz, B.E., Houser, C.R., Tomiyasu, U., Walsh, G.O., DeSalles, A., Rich, J.R., Delgado-Escueta, A., Hippocampal cell loss in posttraumatic human epilepsy. Epilepsia, 2006. 47(8): pp. 1373–1382.
  10. 10. Houser, C.R. and Esclapez, M., Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures. Epilepsy Research, 1996. 26(1): pp. 207–218.
  11. 11. Jiao, Y. and Nadler, V.J., Stereological analysis of GluR2-immunoreactive hilar neurons in the pilocarpine model of temporal lobe epilepsy: correlation of cell loss with mossy fiber sprouting. Experimental Neurology, 2007. 205(2): pp. 569–582.
  12. 12. El-Hassar, L., Esclapez, M., and Bernard, C., Hyperexcitability of the CA1 hippocampal region during epileptogenesis. Epilepsia, 2007. 48(s5): pp. 131–139.
  13. 13. Esclapez, M., Hirsch, J.C., Ben-Ari, Y., Bernard, C., Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. Journal of Comparative Neurology, 1999. 408(4): pp. 449–460.
  14. 14. Maglóczky, Z., Sprouting in human temporal lobe epilepsy: excitatory pathways and axons of interneurons. Epilepsy Research, 2010. 89(1): pp. 52–59.
  15. 15. Thind, K.K., Yamawaki, R., Phanwar, I., Zhang, G., Wen, X., Buckmaster, P.S., Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. Journal of Comparative Neurology, 2010. 518(5): pp. 647–667.
  16. 16. Peng, Z., Zhang, N., Wei, W., Huang, C., A reorganized GABAergic circuit in a model of epilepsy: evidence from optogenetic labeling and stimulation of somatostatin interneurons. The Journal of Neuroscience, 2013. 33(36): pp. 14392–14405.
  17. 17. Hofmann, G., Balgooyen, L., Mattis, J., Deisseroth, K., Buckmaster, P.S., Hilar somatostatin interneuron loss reduces dentate gyrus inhibition in a mouse model of temporal lobe epilepsy. Epilepsia, 2016. 57(6): pp. 977–983.
  18. 18. Zhang, W., Yamawaki, R., Wen, X., Uhl, J., Diaz, J., Prince, D.A., Buckmaster, P.S., Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. The Journal of Neuroscience, 2009. 29(45): p. 14247–14256.
  19. 19. Davenport, C.J., Brown, J.W., Babb, T.L., Sprouting of GABAergic and mossy fiber axons in dentate gyrus following intrahippocampal kainate in the rat. Experimental Neurology, 1990. 109(2): pp. 180–190.
  20. 20. Koyama, R., Tao, K., Sasaki, T., Ichikawa, J., Miyamoto, D., Muramatsu, R., Matsuki, N., Ikegaya, Y., GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy. Nature Medicine, 2012. 18(8): pp. 1271–1278.
  21. 21. Pierce, J.P., McCloskey D.P., and Scharfman H.E., Morphometry of hilar ectopic granule cells in the rat. The Journal of Comparative Neurology, 2011. 519(6): pp. 1196–1218.
  22. 22. Althaus, A.L., Sagher, O., Parent, J.M., Murphy, G.G., Intrinsic neurophysiological properties of hilar ectopic and normotopic dentate granule cells in human temporal lobe epilepsy and a rat model. Journal of Neurophysiology, 2015. 113(4): pp. 1184–1194.
  23. 23. Cameron, M.C., Zhan R.Z., and Nadler V.J., Morphologic integration of hilar ectopic granule cells into dentate gyrus circuitry in the pilocarpine model of temporal lobe epilepsy. The Journal of Comparative Neurology, 2011. 519(11): pp. 2175–2192.
  24. 24. Scharfman, H.E. and Pierce J.P., New insights into the role of hilar ectopic granule cells in the dentate gyrus based on quantitative anatomic analysis and threedimensional reconstruction. Epilepsia, 2012. 53(s1): pp. 109–115.
  25. 25. Shapiro, L.A. and Ribak, C.E., Integration of newly born dentate granule cells into adult brains: hypotheses based on normal and epileptic rodents. Brain Research Reviews, 2005. 48(1): pp. 43–56.
  26. 26. Buckmaster, P.S., Zhang, G., and Yamawaki, R., Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2002. 22(15): pp. 6650–6658.
  27. 27. Danzer, S.C., He, X., Loepke, A.W., McNamara, J.O., Structural plasticity of dentate granule cell mossy fibers during the development of limbic epilepsy. Hippocampus, 2010. 20(1): pp. 113–124.
  28. 28. Ide, Y., Fujiyama, F., Okamoto-Furuta, K., Tamamaki, N., Kaneko, T., Hisatsune, T., Rapid integration of young newborn dentate gyrus granule cells in the adult hippocampal circuitry. European Journal of Neuroscience, 2008. 28(12): pp. 2381–2392.
  29. 29. Tauck, D.L. and Nadler, J.V., Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. The Journal of Neuroscience, 1985. 5(4): pp. 1016–1022.
  30. 30. Zhang, W., Huguenard, J.R., and Buckmaster, P.S., Increased excitatory synaptic input to granule cells from hilar and CA3 regions in a rat model of temporal lobe epilepsy. The Journal of Neuroscience, 2012. 32(4): pp. 1183–1196.
  31. 31. Henderson, K.W., Gupta, J., Tagliatela, S., Litvina, E., Zheng, X., Van Zandt, M.A., Woods, N., Grund, E., Lin, D., Royston, S., Yanagawa, Y., Aaron, G.B., Naegele, J.R., Long-term seizure suppression and optogenetic analyses of synaptic connectivity in epileptic mice with hippocampal grafts of GABAergic interneurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2014. 34(40): pp. 13492–13504.
  32. 32. Meldrum, B., Protection Against Ischemic Brain Damage by Excitatory Amino Acid Antagonists. , in Neurochemical Correlates of Cerebral Ischemia, N.G. Bazan, P. Braquet, and M.D. Ginsberg, Editors. 1992, Springer US: Boston, MA. p. 245-263.
  33. 33. Amaral, D.G. and Witter, M.P., The three-dimensional organization of the hippocampal formation: A review of anatomical data. Neuroscience, 1989. 31(3): pp. 571–591.
  34. 34. Witter, M.P. and Amaral, D.G., Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex. Journal of Comparative Neurology, 1991. 307(3): pp. 437–459.
  35. 35. Witter, M.P. and D.G. Amaral, CHAPTER 21 - Hippocampal Formation A2 - Paxinos, George, in The Rat Nervous System (THIRD EDITION). 2004, Academic Press: Burlington. pp. 635–704.
  36. 36. Ambrogini, P., Cuppini, R., Lattanzi, D., Ciuffoli, S., Frontini, A., Fanelli, M., Synaptogenesis in adultgenerated hippocampal granule cells is affected by behavioral experiences. Hippocampus, 2010. 20(7): pp. 799–810.
  37. 37. Kirschen, G.W., A. Di Antonio, and S. Ge., Chapter 2 - Physiology and Plasticity A2 - Canales, Juan J, in Adult Neurogenesis in the Hippocampus. 2016, Academic Press: San Diego. pp. 19–40.
  38. 38. van Praag, H., Schinder, A.F., Christie, B.R., Toni, N., Palmer, T.D., Gage, F.H., Functional neurogenesis in the adult hippocampus. Nature, 2002. 415(6875): pp. 1030–1034.
  39. 39. Drew, L.J., Fusi, S., and Hen, R., Adult neurogenesis in the mammalian hippocampus: why the dentate gyrus? Learning & Memory, 2013. 20(12): pp. 710–729.
  40. 40. Gross, C.G., Neurogenesis in the adult brain: death of a dogma. Nature Reviews Neuroscience, 2000. 1(1): pp. 67–73.
  41. 41. Ma, D.K., Marchetto, M.C., Guo, J.U., Ming, G., Gage, F.H., Song, H., Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nature Neuroscience, 2010. 13(11): pp. 1338–1344.
  42. 42. Buckmaster, P.S. and Lew, F.H., Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2011. 31(6): pp. 2337–2347.
  43. 43. Lew, F.H. and Buckmaster, P.S., Is there a critical period for mossy fiber sprouting in a mouse model of temporal lobe epilepsy? Epilepsia, 2011. 52(12): pp. 2326–2332.
  44. 44. Murphy, B.L., Pun, R., Yin, H., Faulkner, C., Heterogeneous integration of adult-generated granule cells into the epileptic brain. The Journal of Neuroscience, 2011. 31(1): pp. 105–117.
  45. 45. Case, M.J. and Soltesz, I., Computer Modeling of Epilepsy, in Jasper's Basic Mechanisms of the Epilepsies [Internet], Noebels J.L., et al., Editors. 2012, National Center for Biotechnology Information (US): Bethesda, MD.
  46. 46. Hester, M.S. and Danzer, S.C., Accumulation of abnormal adult-generated hippocampal granule cells predicts seizure frequency and severity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2013. 33(21): pp. 8926–8936.
  47. 47. Parent, J.M., Adult neurogenesis in the intact and epileptic dentate gyrus. Progress in Brain Research, 2007. 163: pp. 529–817.
  48. 48. Shapiro, L.A. and Ribak, C.E., Newly born dentate granule neurons after pilocarpine-induced epilepsy have hilar basal dendrites with immature synapses. Epilepsy Research, 2006. 69(1): pp. 53–66.
  49. 49. Dashtipour, K., Wong, A.M., Obenaus, A., Spigelman, I., Riback, C.E., Temporal profile of hilar basal dendrite formation on dentate granule cells after status epilepticus. Epilepsy Research, 2003. 54(2–3): pp. 141–151.
  50. 50. Spigelman, I., Yan, X.X., Obenaus, A., Lee, E.Y.S., Wasterlain, C.G., Ribak, C.E., Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy. Neuroscience, 1998. 86(1): pp. 109–120.
  51. 51. Singh, S.P., LaSarge, C.L., An, A., McAuliffe, J.J., Danzer, S.C., Clonal analysis of newborn hippocampal dentate granule cell proliferation and development in temporal lobe epilepsy. eNeuro, 2015. 2(6): pp. 1–13.
  52. 52. Botterill, J.J., Brymer, K.J., Caruncho, H.J., Kalynchuk, L.E., Aberrant hippocampal neurogenesis after limbic kindling: relationship to BDNF and hippocampal-dependent memory. Epilepsy & Behavior: E&B, 2015. 47: pp. 83–92.
  53. 53. Korn, M.J., Mandle, Q.J., and Parent, J.M., Conditional disabled-1 deletion in mice alters hippocampal neurogenesis and reduces seizure threshold. Frontiers in Neuroscience, 2016. 10(63): pp. 1–12.
  54. 54. Boulogne, S., Catenoix, H., Ryvlin, P, Rheims, S., Long-lasting seizure-related anxiety in patients with temporal lobe epilepsy and comorbid psychiatric disorders. Epileptic Disorders: International Epilepsy Journal with Videotape, 2015. 17(3): pp. 340–344.
  55. 55. Rocha, L., Alonso-Vanegas, M., Martínez-Juárez, I.E., Orozco-Suárez, S., Escalante-Sant-iago, D., Feria-Romero, I.A., Zavala-Tecuapetla, C., Cisneros, J.M.M., Buentello-García, R.M., Cienfuegos, J., GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors. Frontiers in Cellular Neuroscience, 2014. 8: pp. 442.
  56. 56. Lopes, M.W., Lopes, S., Santos, D., Costa, A., Gonçalves, F., de Mello, N., Prediger, R., Farina, M., Walz, R., Leal, R., Time course evaluation of behavioral impairments in the pilocarpine model of epilepsy. Epilepsy & Behavior: E&B, 2016. 55: pp. 92–100.
  57. 57. Liu, Z., Gatt, A., Werner, S.J., Mikati, M.A., Holmes, G.L., Long-term behavioral deficits following pilocarpine seizures in immature rats. Epilepsy Research, 1994. 19(3): pp. 191–204.
  58. 58. Titiz, A.S., Mahoney, J.M., Testorf, M.E., Holmes, G.L., Scott, R.C., Cognitive impairment in temporal lobe epilepsy: role of online and offline processing of single cell information. Hippocampus, 2014. 24(9): pp. 1129–1145.
  59. 59. Lin, H., Holmes, G.L., Kubie, J.L., Muller, R.U., Recurrent seizures induce a reversible impairment in a spatial hidden goal task. Hippocampus, 2009. 19(9): pp. 817–827.
  60. 60. Weniger, G., Ruhleder, M., Lange, C., Irle, E., Impaired egocentric memory and reduced somatosensory cortex size in temporal lobe epilepsy with hippocampal sclerosis. Behavioural Brain Research, 2012. 227(1): pp. 116–124.
  61. 61. Astur, R.S., Taylor, L.B., Mamelak, A.N., Philpott, L., Sutherland, R.J., Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behavioural Brain Research, 2002. 132(1): pp. 77–84.
  62. 62. Ekstrom, A.D., Kahana, M.J., Caplan, J.B., Fields, T.A., Isham, E.A., Nnewman, E.L., Fried, I., Cellular networks underlying human spatial navigation. Nature, 2003. 425(6954): pp. 184–188.
  63. 63. O'Keefe, J. and Dostrovsky, J., The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Research, 1971. 34(1): pp. 171–175.
  64. 64. Zhang, S., Ye, J., Couey, J.J., Witter, M., Moser, E.I., Moser, M., Functional connectivity of the entorhinal-hippocampal space circuit. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2014. 369(1635): pp. 20120516.
  65. 65. Hafting, T., Fyhn, M., Molden, S., Moser, M., Moser, E.I., Microstructure of a spatial map in the entorhinal cortex. Nature, 2005. 436(7052): pp. 801–806.
  66. 66. Wilent, W.B. and Nitz, D.A., Discrete place fields of hippocampal formation interneurons. Journal of Neurophysiology, 2007. 97(6): pp. 4152–4161.
  67. 67. Ego-Stengel, V. and Wilson, M.A., Spatial selectivity and theta phase precession in CA1 interneurons. Hippocampus, 2007. 17(2): pp. 161–174.
  68. 68. Rosas, K., Parrón, I., Serrano, P., Cimadevilla, J.M.M., Spatial recognition memory in a virtual reality task is altered in refractory temporal lobe epilepsy. Epilepsy & Behavior, 2013. 28(2): pp. 227–231.
  69. 69. Amlerova, J., Laczo, J, Vlcek, K, Javurkova, A., Andel, R., Marusic, P., Risk factors for spatial memory impairment in patients with temporal lobe epilepsy. Epilepsy & Behavior, 2013. 26(1): pp. 57–60.
  70. 70. Cánovas, R., León, I., Serrano, P., Roldán, M.D., Cimadevilla, J.M.M., Spatial navigation impairment in patients with refractory temporal lobe epilepsy: evidence from a new virtual reality-based task. Epilepsy & Behavior, 2011. 22(2): pp. 364–369.
  71. 71. Bohbot, V.D., Kalina, M., Stepankova, K., Spackova, N., Petrides, M., Nadel, L., Spatial memory deficits in patients with lesions to the right hippocampus and to the right parahippocampal cortex. Neuropsychologia, 1998. 36(11): pp. 1217–1238.
  72. 72. Chauvière, L., Rafrafi, N., Thinus-Blanc, C, Bartolomei, F, Esclapez, M., Bernard, C., Early deficits in spatial memory and theta rhythm in experimental temporal lobe epilepsy. The Journal of Neuroscience, 2009. 29(17): pp. 5402–5410.
  73. 73. Inostroza, M., Brotons-Mas, J.R., Laurent, F., Cid, E., de la Prida, L., Specific impairment ofwhat-where-whenepisodic-like memory in experimental models of temporal lobe epilepsy. The Journal of Neuroscience, 2013. 33(45): pp. 17749–17762.
  74. 74. Richard, G.R., Titiz, A., Tyler, A., Holmes, G.L., Scott, R.C., Lenck-Santini, P., Speed modulation of hippocampal theta frequency correlates with spatial memory performance. Hippocampus, 2013. 23(12): pp. 1269–1279.
  75. 75. Sloviter, R.S., Bumanglag, A.V., Schwarcz, R., Frotscher, M., Abnormal dentate gyrus network circuitry in temporal lobe epilepsy. Epilepsia, 2010. 51(s5): pp. 41–41.
  76. 76. Müller, C.J., Gröticke, I., Bankstahl, M., Löscher, W., Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice. Experimental Neurology, 2009. 219(1): pp. 284–297.
  77. 77. Orbán-Kis, K., Mihály, I., Lukács, I., Kiss, R., Izsák, J., Száva, I., Metz, J., Szilágyi, T., Spatial memory deficits in juvenile rats with pilocarpine induced temporal lobe epilepsy. Acta Medica Marisiensis, 2014. 60(5): pp. 191–195.
  78. 78. Pearson, J.N., Schulz, K.M., and Patel, M., Specific alterations in the performance of learning and memory tasks in models of chemoconvulsant-induced status epilepticus. Epilepsy Research, 2014. 108(6): pp. 1032–1040.
  79. 79. Gröticke, I., Hoffmann, K., and Löscher, W., Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Experimental Neurology, 2008. 213(1): pp. 71–83.
  80. 80. Gernert, M., Thompson, K.W., Löscher, W., Tobin, A.J., Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats. Experimental Neurology, 2002. 176(1): pp. 183–192.
  81. 81. Xu, Q., Cobos, I., Cruz, E., Rubenstein, J.L., Anderson, S.A., Origins of cortical interneuron subtypes. The Journal of Neuroscience, 2004. 24(11): pp. 2612–2622.
  82. 82. Wichterle, H., Turnbull, D.H., Nery, S., Fishell, G., Alvarez-Buylla, A. , In utero fate mapping reveals distinct migratory pathways and fates of neurons born in the mammalian basal forebrain. Development, 2001 128: pp. 3759–3771.
  83. 83. Anderson, S.A., Marin, O., Horn, C., Jennings, K., Rubenstein, J.L.R., Distinct cortical migrations from the medial and lateral ganglionic eminences. Development, 2001 128: pp. 353–363.
  84. 84. Wichterle, H., Garcia-Verdugo, J., Herrera, D.G., Alvarez-Buylla, A., Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nature Neuroscience, 1999. 2(5): pp. 461–466.
  85. 85. Alvarez-Dolado, M., Calcagnotto, M., Karkar, K.M., Southwell, D.G., Jones-Davis, D.M., Estrada, R.C., Rubenstein, J.L.R., Alvarez-Buylla, A., Baraban, S.C., Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2006. 26(28): pp. 7380–7389.
  86. 86. Howard, M.A. and Baraban, S.C., Synaptic integration of transplanted interneuron progenitor cells into native cortical networks. Journal of Neurophysiology, 2016. 116(2): pp. 472–478.
  87. 87. Calcagnotto, M.E., Zipancic, I., Piquer-Gil, M., Mello, L.E., Álvarez‐Dolado, M., Grafting of GABAergic precursors rescues deficits in hippocampal inhibition. Epilepsia, 2010. 51(Suppl 3): pp. 66–70.
  88. 88. Baraban, S.C., Southwell, D.G., Estrada, R.C., Jones, D.L., Sebe, J.Y., Alfaro-Cervello, C., García-Verdugo, J.M., Rubenstein, J.L., Alvarez-Buylla, A., Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(36): pp. 15472–15477.
  89. 89. Gilani, A.I., Chohan, M.O., Inan, M., Schobel, S.A., Chaudhury, N.H., Paskewitz, S., Chuhma, N., Glickstein, S., Merker, R.J., Xu, Q., Small, S.A., Anderson, S.A., Ross, M.E., Moore, H., Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition. Proceedings of the National Academy of Sciences of the United States of America, 2014. 111(20): pp. 7450–7455.
  90. 90. Waldau, B., Hattiangady, B., Kuruba, R., Shetty, A.K., Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells (Dayton, Ohio), 2010. 28(7): pp. 1153–1164.
  91. 91. Inostroza, M., Cid, E., Brotons-Mas, J., Gal, B., Aivar, P., Uzcategui, Y.G., Sandi, C., de la Prida, L., Hippocampal-dependent spatial memory in the water maze is preserved in an experimental model of temporal lobe epilepsy in rats. PloS One, 2011. 6(7): e22372.
  92. 92. Mohajeri, M.H., Madani, R., Saini, K., Lipp, H.P., Nitsch, R.M., Wolfer, D.P., The impact of genetic background on neurodegeneration and behavior in seizured mice. Genes, Brain and Behavior, 2004 3(4): pp. 228–239.
  93. 93. Kumar, S.S. and Buckmaster, P.S., Hyperexcitability, Interneurons, and loss of GABAergic synapses in entorhinal cortex in a model of temporal lobe epilepsy. The Journal of Neuroscience, 2006. 26(17): pp. 4613–4623.
  94. 94. Germain, N.D., Banda, E.C., Becker, S., Naegele, J.R., Grabel, L.B., Derivation and isolation of NKX2.1-positive basal forebrain progenitors from human embryonic stem cells. Stem Cells and Development, 2013. 22(10): pp. 1477–1489.
  95. 95. Liu, Y., Huisheng, L, Sauvey, C., Yao, L., Zarnowska, E.D., Zhang, S., Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nature Protocols, 2013. 8(9): pp. 1670–1679.
  96. 96. Tyson, J.A., Goldberg, E.M., Maroof, A.M., Xu, Q., Petros, T.I., Anderson, S.A., Duration of culture and sonic hedgehog signaling differentially specify PV versus SST cortical interneuron fates from embryonic stem cells. Development, 2015. 142(7): pp. 1267–1278.
  97. 97. Nicholas, C.R., Chen, J., Tang, Y., Southwell, D.G., Chalmers, N., Vogt, D., Arnold, C.M., Chen, Y.J., Stanley, E.G., Elefanty, A.G., Sasai, Y., Alvarez-Buylla, A., Rubenstein, J., Kriegstein, A.R. , Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell, 2013. 12(5): pp. 573–586.
  98. 98. Kim, T.G., Yao, R., Monnel, T., Cho, J., Vasudevan, A., Koh, A., Peeyush, K.T., Moon, M., Datta, D., Bolshakov, V.Y., Kim, K., Chung, S., Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. Stem Cells, 2014. 32(7): pp. 1789–1804.
  99. 99. Maroof, A.M., Keros, S., Tyson, J.A., Ying, S., Ganat, Y.M., Merkle, F.T., Liu, B., Goulburn, A., Stanley, E.G., Elefanty, A.G., Widmer, H., Eggan, K., Goldstein, P.A., Anderson, S.A., Studer, L., Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell, 2013. 12(5): pp. 559–572.
  100. 100. Ahn, S., Kim, T., Kim, K., Chung, S., Differentiation of human pluripotent stem cells into medial ganglionic eminence vs caudal ganglionic eminence cells. Methods, 2016. 101: pp. 103–112.
  101. 101. Carpentino, J.E., Hartman, N.W., Grabel, L.B., Naegele, J.R., Region-specific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures. Journal of Neuroscience Research, 2008. 86(3): pp. 512–524.
  102. 102. Lee, H., Yun, S., Kim, I., Lee, I., Shin, J., Park, S., Kim, W., Park, K., Human fetal brain-derived neural stem/progenitor cells grafted into the adult epileptic brain restrain seizures in rat models of temporal lobe epilepsy. PloS One, 2014. 9(8): e104092.
  103. 103. Chen, C.Y., Plocik, A., Anderson, N.C., Moakley, D., Boyi, T., Dundes, C., Lassiter, C., Graveley, B.R., Grabel, L., Transcriptome and in vitro differentiation profile of human embryonic stem cell derived NKX2.1-positive neural progenitors. Stem Cell Reviews and Reports, 2016. 12(6): pp. 744–756.
  104. 104. Goulburn, A.L., Alden, D., Davis, R.P., Micallef, S.J., Ng, E.S., Yu, Q.C., Lim, S.M., Soh, C.L., Elliott, D.A., Hatzistavrou, T., Bourke, J., Watmuff, B., Lang, R.J., Haynes, J.M., Pouton, C.W., Giudice, A., Trounson, A.O., Anderson, S.A., Stanley, E.G., Elefanty, A.G., A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives. Stem Cells, 2011. 29(3): pp. 462–473.
  105. 105. Tyson, J.A., Goldberg, E.M., Maroof, A.M., Xu, Q., Petros, T.J., Anderson, S.A., Duration of culture and sonic hedgehog signaling differentially specify PV versus SST cortical interneuron fates from embryonic stem cells. Development (Cambridge, England), 2015. 142(7): pp. 1267–1278.
  106. 106. Petros, T.J., Maurer, C.W., and Anderson, S.A., Enhanced derivation of mouse ESC-derived cortical interneurons by expression of Nkx2.1. Stem Cell Research, 2013. 11(1): pp. 647–656.
  107. 107. Germain, N.D., Hartman, N.W., Cai, C., Becker, S., Naegele, J.R., Grabel, L.B., Teratocarcinoma formation in embryonic stem cell-derived neural progenitor hippocampal transplants. Cell Transplantation, 2012. 21(8): pp. 1603.
  108. 108. Shultz, L.D., Ishikawa, F., and Greiner, D.L., Humanized mice in translational biomedical research. Nature Reviews. Immunology, 2007. 7(2): pp. 118–130.
  109. 109. Maisano, X., Litvina, E., Tagliatela, S., Aaron, G.B., Grabel, L.B., Naegele, J.R., Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2012. 32(1): pp. 46–61.
  110. 110. Cunningham, M., Cho, J., Leung, A., Savvidis, G., Ahn, S., Moon, M., Lee, P., Han, J.J., Azimi, N., Kim, K., Bolshakov, V.Y., Chung, S., hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell, 2014. 15(5): pp. 559–573.
  111. 111. Hunt, R.F., Girskis, K.M., Rubenstein, J.L., Alvarez-Buylla, A., Baraban, S.C., GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nature Neuroscience, 2013. 16(6): pp. 692–697.
  112. 112. Faure, J.B., Akimana, G., Carneiro, J.E.M., Cosquer, B., Ferrandon, A., Geiger, K., Koning, E., Penazzi, L., Cassel, J., Nehlig, A., A comprehensive behavioral evaluation in the lithiumpilocarpine model in rats: effects of carisbamate administration during status epilepticus. Epilepsia, 2013. 54(7): pp. 1203–1213.
  113. 113. Antunes, M. and Biala, G., The novel object recognition memory: neurobiology, test procedure, and its modifications. Cognitive Processing, 2012. 13(2): pp. 93–110.
  114. 114. Ennaceur, A. and Delacour, J., A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behavioural Brain Research, 1988. 31(1): pp. 47–59.
  115. 115. Rosenfeld, C.S. and Ferguson, S.A., Barnes maze testing strategies with small and large rodent models. Journal of Visualized Experiments, 2014. 84: e51194.
  116. 116. Levin, E.D., Psychopharmacological effects in the radial-arm maze. Neuroscience & Biobehavioral Reviews, 1988. 12(2): pp. 169–175.
  117. 117. Hodges, H., Maze procedures: the radial-arm and water maze compared. Cognitive Brain Research, 1996. 3(3–4): pp. 167–181.
  118. 118. Levy, A., Kluge, P.B., and Elsmore, T.F., Radial arm maze performance of mice: acquisition and atropine effects. Behavioral and Neural Biology, 1983. 39(2): pp. 229–240.
  119. 119. Brown, M.F., Rish, P.A., VonCulin, J.E., Edberg, J.A., Spatial guidance of choice behavior in the radial-arm maze. Journal of Experimental Psychology Animal Behavior Processes, 1993. 19(3): pp. 195–214.
  120. 120. Deacon, R.M.J. and Rawlins, N.J.P., T-maze alternation in the rodent. Nature Protocols, 2006. 1(1): pp. 7–12.
  121. 121. Gong, D.-Y. and Choi, Y.-S., Development of new analytical method evaluating working memory on Y maze. Journal of Life Science, 2016. 26(2): pp. 234–240.
  122. 122. Koolhaas, J.M., Coppens, C.M., de Boer, S.F., Buwalda, B., Meerlo, P., Timmermans, P., The resident-intruder paradigm: a standardized test for aggression, violence and social stress. Journal of Visualized Experiments, 2013. 77: e4367.
  123. 123. Komada, M., Takao, K., and Miyakawa, T., Elevated plus maze for mice. Journal of Visualized Experiments, 2008. 22: e1088.
  124. 124. Sidor, M.M., Rilett, K., and Foster, J.A., Validation of an automated system for measuring anxiety-related behaviours in the elevated plus maze. Journal of Neuroscience Methods, 2010. 188(1): pp. 7–13.
  125. 125. Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J., Dourish, C.T., Behavioural and pharmacological characterisation of the elevatedzero-mazeas an animal model of anxiety. Psychopharmacology, 1994. 116(1): pp. 56–64.
  126. 126. Kulkarni, S.K., Singh, K., and Bishnoi, M., Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Methods and Findings in Experimental and Clinical Pharmacology, 2007. 29(5): pp. 343–348.
  127. 127. Misslin, R., Belzung, C., and Vogel, E., Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behavioural Processes, 1989. 18(1–3): pp. 119–132.
  128. 128. Kulesskaya, N. and Voikar, V., Assessment of mouse anxiety-like behavior in the lightdark box and open-field arena: role of equipment and procedure. Physiology & Behavior, 2014. 133: pp. 30–38.
  129. 129. Südhof, T.C., Neuroligins and neurexins link synaptic function to cognitive disease. Nature, 2008. 455(7215): pp. 903–911.
  130. 130. Craig, A.M. and Kang, Y., Neurexin-neuroligin signaling in synapse development. Current Opinion in Neurobiology, 2007. 17(1): pp. 43–52.
  131. 131. Papadopoulos, T. and Soykan, T., The role of collybistin in gephyrin clustering at inhibitory synapses: facts and open questions. Frontiers in Cellular Neuroscience, 2011. 5: pp. 11.
  132. 132. Essrich, C., Lorez, M., Benson, J.A., Fritschy, J.M., Lüscher, B., Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nature Neuroscience, 1998. 1(7): pp. 563–571.
  133. 133. Poulopoulos, A., Aramuni, G., Meyer, G., Soykan, T., Hoon, M., Papadopoulos, T., Zhang, M., Paarmann, I., Fuchs, C., Harvey, K., Jedlicka, P., Schwarzacher, S.W., Betz, H., Harvey, R.J., Brose, N., Zhang, W., Varoqueaux, F., Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron, 2009. 63(5): pp. 628–642.
  134. 134. Jacob, T.C., Bogdanov, Y.D., Magnus, C., Saliba, R.S., Kittler, J.T., Haydon, P.G., Moss, S.J., Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors. The Journal of Neuroscience, 2005. 25(45): pp. 10469–10478.
  135. 135. Varoqueaux, F., Aramuni, G., Rawson, R.L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Südhof, T.C., Brose, N., Neuroligins determine synapse maturation and function. Neuron, 2006. 51(6): pp. 741–754.
  136. 136. Babaev, O., Botta, P., Meyer, E., Müller, C., Ehrenreich, H., Brose, N., Lüthi, A., Krueger-Burg, D., Neuroligin 2 deletion alters inhibitory synapse function and anxiety-associated neuronal activation in the amygdala. Neuropharmacology, 2016. 100: pp. 56–65.
  137. 137. Gibson, J.R., Huber, K.M., and Südhof, T.C., Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2009. 29(44): pp. 13883–13897.
  138. 138. Jedlicka, P., Hoon, M., Papadopoulos, T., Vlachos, A., Winkels, R., Poulopoulos, A., Betz, H., Deller, T., Brose, N., Varoqueaux, F., Schwarzacher, S.W., Increased dentate gyrus excitability in neuroligin-2-deficient mice in vivo. Cerebral Cortex, 2011. 21(2): pp. 357–367.
  139. 139. Hines, R.M., Wu, L., Hines, D.J., Steenland, H., Mansour, S., Dahlhaus, R., Singaraja, R.R., Cao, X., Sammler, E., Hormuzdi, S.G., Zhuo, M., El-Husseini, A., Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression. The Journal of Neuroscience, 2008. 28(24): pp. 6055–6067.
  140. 140. Liang, J., Xu, W., Hsu, Y.T., Yee, A.X., Chen, L., Südhof, T.C., Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments. Molecular Psychiatry, 2015. 20(7): pp. 850–859.
  141. 141. Papadopoulos, T., Korte, M., Eulenburg, V., Kubota, H., Retiounskaia, M., Harvey, R.J., Harvey, K., O’Sullivan, G.A., Laube, B., Hülsmann, S., Geiger, J.R.R., Betz, H., Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. The EMBO Journal, 2007. 26(17): pp. 3888–3899.
  142. 142. Prior, P., Schmitt, B., Grenningloh, G., Pribilla, I., Multhaup, G., Beyreuther, K., Maulet, Y., Werner, P., Langosch, D., Kirsch, J., Betz, H., Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein. Neuron, 1992. 8(6): pp. 1161–1170.
  143. 143. Tyagarajan, S.K. and Fritschy, J.-M.M., Gephyrin: a master regulator of neuronal function? Nature Reviews. Neuroscience, 2014. 15(3): pp. 141–156.
  144. 144. Kneussel, M., Brandstätter, J.H., Laube, B., Stahl, S., Müller, U., Betz, H., Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 1999. 19(21): pp. 9289–9297.
  145. 145. Lüscher, B. and Keller, C.A., Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses. Pharmacology & Therapeutics, 2004. 102(3): pp. 195–221.
  146. 146. Thind, K.K., Yamawaki, R., Phanwar, I., Zhang, G., Wen, X., Buckmaster, P.S., Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. Journal of Comparative Neurology, 2010. 518(5): pp. 647–677.
  147. 147. Fang, M., Shen, L., Yin, H., Pan, Y., Wang, L., Chen, D., Xi, Z., Xiao, Z., Wang, X., Zhou, S., Downregulation of gephyrin in temporal lobe epilepsy neurons in humans and a rat model. Synapse (New York, N.Y.), 2011. 65(10): pp. 1006–1014.
  148. 148. Kins, S., Betz, H., and Kirsch, J., Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin. Nature Neuroscience, 2000. 3(1): pp. 22–29.
  149. 149. Harvey, K., Duguid, I.C., Alldred, M.J., Beatty, S.E., Ward, H., Keep, N.H., Lingenfelter, S.E., Pearce, B.R., Lundgren, J., Owen, M.J., Smart, T.G., Lüscher, B., Rees, M.I., Harvey, R.J., The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2004. 24(25): pp. 5816–5826.
  150. 150. Saiepour, L., Fuchs, C., Patrizi, A., Sassoè-Pognetto, M., Harvey, R.J., Harvey, K., Complex role of collybistin and gephyrin in GABAA receptor clustering. Journal of Biological Chemistry, 2010. 285(38): pp. 29623–29631.
  151. 151. Varoqueaux, F., Jamain, S., and Brose, N., Neuroligin 2 is exclusively localized to inhibitory synapses. European Journal of Cell Biology, 2004. 83(9): pp. 449–456.
  152. 152. Dean, C. and Dresbach, T., Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends in Neurosciences, 2006. 29(1): pp. 21–29.
  153. 153. Siddiqui, T.J. and Craig, A.M., Synaptic organizing complexes. Current Opinion in Neurobiology, 2011. 21(1): pp. 132–143.
  154. 154. Blundell, J., Tabuchi, K., Bolliger, M.F., Blaiss, C.A., Brose, N., Liu, X., Südhof, T.C., Powell, C.M., Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes, Brain, and Behavior, 2009. 8(1): pp. 114–126.
  155. 155. Maćkowiak, M., Mordalska, P., and Wędzony, K., Neuroligins, synapse balance and neuropsychiatric disorders. Pharmacological Reports: PR, 2014. 66(5): pp. 830–835.
  156. 156. van der Kooij, M.A., Fantin, M., Kraev, I., Korshunova, I., Grosse, J., Zanoletti, O., Guirado, R., Garcia-Mompó, C., Nacher, J., Stewart, M.G., Berezin, V., Sandi, Carmen., Impaired hippocampal neuroligin-2 function by chronic stress or synthetic peptide treatment is linked to social deficits and increased aggression. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 2014. 39(5): pp. 1148–1158.
  157. 157. Sun, C., Cheng, M., Qin, R., Liao, D., Chen, T., Koong, F., Chen, G., Chen, Chia., Identification and functional characterization of rare mutations of the neuroligin-2 gene(NLGN2) associated with schizophrenia. Human Molecular Genetics, 2011. 20(15): pp. 3042–3051.
  158. 158. Graf, E.R., Zhang, X., Jin, S., Linhoff, M.W., Craig, A., Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell, 2004. 119(7): pp. 1013–1026.
  159. 159. Zhang, C., Atasoy, D., Araç, D., Yang, X., Fucillo, M.V., Robison, A.J., Ko, J., Brunger, A.T., Südhof, T.C., Neurexins physically and functionally interact with GABA(A) receptors. Neuron, 2010. 66(3): pp. 403–416.
  160. 160. Dong, N., Qi, J., and Chen, G., Molecular reconstitution of functional GABAergic synapses with expression of neuroligin-2 and GABAA receptors. Molecular and Cellular Neuroscience, 2007. 35(1): pp. 14–23.
  161. 161. Loup, F., Wieser, H.G., Yonekawa, Y., Aguzzi, A., Fritschy, J.M., Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2000. 20(14): pp. 5401–5419.
  162. 162. Poulter, M.O., Brown, L.A., Tynan, S., Willick, G., William, R., McIntyre, D.C., Differential expression of alpha1, alpha2, alpha3, and alpha5 GABAA receptor subunits in seizure-prone and seizure-resistant rat models of temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 1999. 19(11): pp. 4654–4661.
  163. 163. Rice, A., Rafiq, A., Shapiro, S.M., Jakoi, E.R., Coulter, D.A., DeLorenzo, R.J., Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proceedings of the National Academy of Sciences of the United States of America, 1996. 93(18): pp. 9665–9669.
  164. 164. Brown, N., Kerby, J., Bonnert, T.P., Whiting, P.J., Wafford, K.A., Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. British Journal of Pharmacology, 2002. 136(7): pp. 965–974.
  165. 165. Saxena, N.C. and Macdonald, R.L., Assembly of GABAA receptor subunits: role of the delta subunit. The Official Journal of the Society for Neuroscience, 1994. 14(11): pp. 7077–7086.
  166. 166. Stell, B.M., Brickley, S.G., and Tang, C.Y., Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors. Proceedings of the National Academy of Sciences United States of America, 2003. 100(24): pp. 14439–14444.
  167. 167. Wu, X., Wu, Z., Ning, G., Guo, Y., Ali, Rashid., Macdonald, R.L., Blas, A.L., Luscher, B., Chen, G., γ-aminobutyric acid type A (GABAA) receptor α subunits play a direct role in synaptic versus extrasynaptic targeting. Journal of Biological Chemistry, 2012. 287(33): pp. 27417–27430.
  168. 168. Wisden, W., Laurie, D.J., Monyer, H., Seeburg, P.H., The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 1992. 12(3): pp. 1040–1062.
  169. 169. Peng, Z., Huang, C.S., Stell, B.M., Mody, I., Houser, C.R., Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 2004. 24(39): pp. 8629–8639.

Written By

Meghan A. Van Zandt and Janice R. Naegele

Submitted: July 20th, 2016 Reviewed: December 12th, 2016 Published: June 21st, 2017